Pegylated interferon-α2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysersBARRIL, G; QUIROGA, J. A; SANZ, P et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 1, pp 37-44, issn 0269-2813, 8 p.Article

Reduction in p48-ISGFγ levels confers resistance to Interferon-α_2a in MHCC97 cellsWU, Wei-Zhong; SUN, Hui-Chuan; GAO, Yan-Qin et al.Oncology. 2004, Vol 67, Num 5-6, pp 428-440, issn 0030-2414, 13 p.Article

Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patientsGOWIN, Krisstina; THAPALIYA, Prakash; CAMORIANO, John et al.Haematologica (Roma). 2012, Vol 97, Num 10, pp 1570-1573, issn 0390-6078, 4 p.Article

Early Serum HBsAg Drop : A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative PatientsMOUCARI, Rami; MACKIEWICZ, Vincent; VALLA, Dominique et al.Hepatology (Baltimore, Md.). 2009, Vol 49, Num 4, pp 1151-1157, issn 0270-9139, 7 p.Article

Interferon Alpha-2a Reduces Early Erythema After Full-Thickness Skin Graft in the PigJUN SIK KIM; SON, Daegu; HYUN HWANG, O et al.Dermatologic surgery. 2009, Vol 35, Num 10, pp 1514-1524, issn 1076-0512, 11 p.Article

Treatment of patients with chronic hepatitis B who have failed previous antiviral treatment with pegylated interferon α2a (40 kDa; PEGASYS®)CHAN, Henry L.-Y; WONG, Vincent W.-S; CHIM, Angel M.-L et al.Antiviral therapy (London). 2008, Vol 13, Num 4, pp 555-562, issn 1359-6535, 8 p.Article

Interféron : IntronA®, Roféron® = Interferon : IntronA®, Roferon®GAUDY-MARQUESTE, C; GROB, J.-J.Annales de dermatologie et de vénéréologie. 2007, Vol 134, Num 12, pp 917-921, issn 0151-9638, 5 p.Article

Fermentation process optimization of recombinant Saccharomyces cerevisiae for the production of human interferon-α2aJU CHU; SILIANG ZHANG; YINGPING ZHUANG et al.Applied biochemistry and biotechnology. 2003, Vol 111, Num 3, pp 129-137, issn 0273-2289, 9 p.Article

Penile Paraffinoma Developing During Treatment With Pegylated Interferon Alfa-2a for Chronic Hepatitis C Virus InfectionBACHMEYER, Claude; MOGUELET, Philippe; GOMBEAUD, Thierry et al.Archives of dermatology (1960). 2011, Vol 147, Num 10, pp 1232-1233, issn 0003-987X, 2 p.Article

HVR-1 heterogeneity during treatment with telaprevir with or without pegylated interferon alfa-2aLANGE, Christian M; SUSSER, Simone; HERRMANN, Eva et al.Scandinavian journal of gastroenterology. 2011, Vol 46, Num 11, pp 1362-1368, issn 0036-5521, 7 p.Article

RG7128 Alone or in Combination with Pegylated Interferon-α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV-Infected PatientsLE POGAM, Sophie; SESHAADRI, Amritha; NAJERA, Isabel et al.The Journal of infectious diseases. 2010, Vol 202, Num 10, pp 1510-1519, issn 0022-1899, 10 p.Article

Successful treatment of verruca plantaris with a single sublesional injection of interferon-α2aAKSAKAL, A. A; OZDEN, M. G; ATAHAN, C et al.Clinical and experimental dermatology (Print). 2009, Vol 34, Num 1, pp 16-19, issn 0307-6938, 4 p.Article

Randomized dose-escalation study evaluating peginterferon Alfa-2a in patients with metastatic malignant melanomaDUMMER, Reinhard; GARBE, Claus; THOMPSON, John A et al.Journal of clinical oncology. 2006, Vol 24, Num 7, pp 1188-1194, issn 0732-183X, 7 p.Article

Peginterferon Alfa-2a: A review of approved and investigational usesMATTHEWS, S. James; MCCOY, Christopher.Clinical therapeutics. 2004, Vol 26, Num 7, pp 991-1025, issn 0149-2918, 35 p.Article

Long-term Efficacy and Safety of Low-Dose and Dose-Escalating Interferon Alfa-2a Therapy in Refractory Behçet UveitisONAL, Sumru; KAZOKOGLU, Haluk; KOC, Aylin et al.Archives of ophthalmology (1960). 2011, Vol 129, Num 3, pp 288-294, issn 0003-9950, 7 p.Article

Safety and Effectiveness of Interferon Alpha-2a in Treatment of Patients with Behçet's Uveitis Refractory to Conventional TreatmentsSOBACI, Güngör; ERDEM, Uzeyir; DURUKAN, A. Hakan et al.Ophthalmology (Rochester, MN). 2010, Vol 117, Num 7, pp 1430-1435, issn 0161-6420, 6 p.Article

L'interféron pégylé dans l'hépatite C = Interferon alfa-2b in treatment of hepatitis CHEZODE, Christophe; DHUMEAUX, Daniel.Hépato-gastro (Montrouge). 2001, Vol 8, Num 6, pp 451-456, issn 1253-7020Article

Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirinLARREY, Dominique; CARENCO, Christophe; GUYADER, Dominique et al.Antiviral therapy (London). 2012, Vol 17, Num 5, pp 927-932, issn 1359-6535, 6 p.Article

Treatment of mooren's ulcer with topical administration of interferon alfa 2aERDEM, Uzeyir; KERIMOGLU, Hurkan; GUNDOGAN, Fatih Cakir et al.Ophthalmology (Rochester, MN). 2007, Vol 114, Num 3, pp 446-449, issn 0161-6420, 4 p.Article

Genes transcriptionally modulated by interferon α2a correlate with the cytokine activityIOLASCON, Achille; VOLINIA, Stefano; INDACO, Stefania et al.Haematologica (Roma). 2004, Vol 89, Num 9, pp 1046-1053, issn 0390-6078, 8 p.Article

Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitisBERTINO, Gaetano; ARDIRI, Annalisa; BOEMI, Roberta et al.European journal of clinical pharmacology. 2010, Vol 66, Num 10, pp 1055-1063, issn 0031-6970, 9 p.Article

Pharmacodynamics of PEG-IFN-α-2a and HCV Response as a Function of IL28B Polymorphism in HIV/ HCV-Coinfected PatientsAFFONSO DE ARAUJO, Evaldo Stanislau; DAHARI, Harel; COTLER, Scott J et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 56, Num 2, pp 95-99, issn 1525-4135, 5 p.Article

In-tube solid-phase microextraction with molecularly imprinted polymer to determine interferon alpha 2a in plasma sample by high performance liquid chromatographyRODRIGUES CHAVES, Andréa; COSTA QUEIROZ, Maria Eugênia.Journal of chromatography. 2013, Vol 1318, pp 43-48, issn 0021-9673, 6 p.Article

Comparative efficacy of pegylated interferons α-2a and 2b in the treatment of HBeAg-negative chronic Hepatitis B infectionKARABAY, Oguz; TUNA, Nazan; ESEN, Saban et al.European journal of gastroenterology & hepatology. 2012, Vol 24, Num 11, pp 1296-1301, issn 0954-691X, 6 p.Article

New method for the synthesis and purification of branched mPEG₂lysGONZALEZ, Marianela; GRAU, Ricardo J. A; VAILLARD, Santiago E et al.Reactive & functional polymers. 2012, Vol 72, Num 1, pp 107-113, issn 1381-5148, 7 p.Article